We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Projects granted during 2014 that have a primary purpose of basic research: oncology.
Volume 21 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Projects granted during 2014 that have a primary purpose of translational and applied research: human cancer.
Information on the programme, including commissioning, quality assurance, education and training.
This document explains the Prostate Cancer Risk Management Programme (PCRMP), PSA testing and evidence against a national screening programme.
How to support patients in accessing population screening programmes and obtaining screening results.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
Information for patients, public and health care professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.